Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 6, 2011, Pages 638-642

  Sutedja, N A ^a   Van Der Schouw, Y T ^b   Fischer, K ^b   Sizoo, E M ^b   Huisman, M H B ^a   Veldink, J H ^a   Van Den Berg, Leonard L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FORCED VITAL CAPACITY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STROKE; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK;

EID: 79955762554     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.236752     Document Type: Article

References (28)

1. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-94. (Pubitemid 36935331)
2. Van Vught PW, Sutedja NA, Veldink JH, et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 2005;65:1643-5. (Pubitemid 41689483)
3. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001;28:131-8. (Pubitemid 32538057)
4. Greenway MJ, Andersen PM, Russ C, et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 2006;38:411-13.
5. Cronin S, Greenway MJ, Ennis S, et al. Elevated serum angiogenin levels in ALS. Neurology 2006;67:1833-6. (Pubitemid 44900762)
6. Wu D, Yu W, Kishikawa H, et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 2007;62:609-17.
7. Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 2008;11:420-2. (Pubitemid 351441888)
8. Regan C, Katona C, Walker Z, et al. Relationship of vascular risk to the progression of Alzheimer disease. Neurology 2006;67:1357-62. (Pubitemid 44632057)
9. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-51. (Pubitemid 41170713)
10. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005;64:494-500. (Pubitemid 40189869)
11. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009;66:343-8.
12. Armon C, Kurland LT, O'Brien PC, et al. Antecedent medical diseases in patients with amyotrophic lateral sclerosis. A population-based case-controlled study in Rochester, Minn, 1925 through 1987. Arch Neurol 1991;48:283-6.
13. Zoccolella S, Simone IL, Lamberti P, et al. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology 2008;70:222-5.
14. Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008;70:1004-9. (Pubitemid 351451324)
15. Chio A, Calvo A, Ilardi A, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 2009;73:1681-5.
16. Muller M, Grobbee DE, Aleman A, et al. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 2007;190:143-9. (Pubitemid 44908308)
17. Aleman A, Muller M, de Haan EH, et al. Vascular risk factors and cognitive function in a sample of independently living men. Neurobiol Aging 2005;26:485-90. (Pubitemid 40093932)
18. Boker LK, van Noord PA, van der Schouw YT, et al. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European prospective investigation into cancer and nutrition. Eur J Epidemiol 2001;17:1047-53.
19. van der AD, Marx JJ, Grobbee DE, et al. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 2006;113:1942-9.
20. Dalmeijer GW, Olthof MR, Verhoef P, et al. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr 2008;62:386-94. (Pubitemid 351358918)
21. Nakhai-Pour HR, Grobbee DE, Bots ML, et al. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. J Hum Hypertens 2007;21:949-55. (Pubitemid 350162703)
22. Beghi E, Logroscino G, Chio A, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 2006;1762:1150-7. (Pubitemid 44750581)
23. Scarmeas N, Shih T, Stern Y, et al. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 2002;59:773-5.
24. Desport JC, Torny F, Lacoste M, et al. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2:202-7. (Pubitemid 43827922)
25. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-34. (Pubitemid 32802018)
26. Dupuis L, Oudart H, Rene F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 2004;101:11159-64. (Pubitemid 38989600)
27. Dupuis L, Pradat PF, Ludolph AC, et al. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011;10:75-82.
28. Eikelboom JW, Lonn E, Genest J Jr, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75. (Pubitemid 29424631)